Facetten
Zugriff
Einrichtung
Medientyp
- Text 15
Karte
Erscheinungsjahr
Autor/in
- Belleville, Erik
- Fasching, Peter A 13
- Janni, Wolfgang 11
- Müller, Volkmar 11
- Fehm, Tanja N 9
- alle zeigen
Sprache
- Englisch 15
15 Einträge gefunden
-
Update Breast Cancer 2021 Part 4 - Prevention and Early Stages
- Thomssen, Christoph
- Fehm, Tanja N
- Stickeler, Elmar
- Fasching, Peter A
- Janni, Wolfgang
- Kolberg-Liedtke, Cornelia
- Kolberg, Hans-Christian
-
Update Mammakarzinom 2021 Teil 5 – fortgeschrittenes Mammakarzinom, Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer
- Lüftner, Diana
- Schütz, Florian
- Stickeler, Elmar
- Fasching, Peter A
- Janni, Wolfgang
- Kolberg-Liedtke, Cornelia
- Kolberg, Hans-Christian
-
Update Mammakarzinom 2022 Teil 1 – Brustkrebs in frühen Krankheitsstadien, Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer
- Welslau, Manfred
- Müller, Volkmar
- Lüftner, Diana
- Schütz, Florian
- Stickeler, Elmar
- Fasching, Peter A
- Janni, Wolfgang
-
Update Mammakarzinom 2022 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien, Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer
- Müller, Volkmar
- Welslau, Manfred
- Lüftner, Diana
- Schütz, Florian
- Stickeler, Elmar
- Fasching, Peter A
- Janni, Wolfgang
-
Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients
- Lux, Michael P
- Schneeweiss, Andreas
- Hartkopf, Andreas D
- Müller, Volkmar
- Janni, Wolfgang
- Belleville, Erik
- Stickeler, Elmar
-
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer
- Lüftner, Diana
- Hartkopf, Andreas D
- Lux, Michael P
- Overkamp, Friedrich
- Tesch, Hans
- Titzmann, Adriana
- Pöschke, Patrik
-
Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and Biomarkers
- Ditsch, Nina
- Stickeler, Elmar
- Behrens, Annika
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
- Hartkopf, Andreas D
-
Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel
- Fehm, Tanja N
- Stickeler, Elmar
- Fasching, Peter A
- Janni, Wolfgang
- Kolberg-Liedtke, Cornelia
- Kolberg, Hans-Christian
- Lüftner, Diana
-
Update Breast Cancer 2021 Part 1 - Prevention and Early Stages
- Stickeler, Elmar
- Aktas, Bahriye
- Behrens, Annika
- Belleville, Erik
- Ditsch, Nina
- Fasching, Peter A
- Fehm, Tanja N
-
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
-
Update Breast Cancer 2020 Part 3 - Early Breast Cancer
- Huober, Jens
- Schneeweiss, Andreas
- Hartkopf, Andreas D
- Müller, Volkmar
- Lux, Michael P
- Janni, Wolfgang
- Ettl, Johannes
-
-
Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer
- Tesch, Hans
- Müller, Volkmar
- Wöckel, Achim
- Ettl, Johannes
- Belleville, Erik
- Schütz, Florian
- Hartkopf, Andreas